original ) (raw )Immunomodulators as adjunctive therapy for HIV-1 infection
Sean Emery
Journal of Clinical Virology, 2001
View PDFchevron_right
Evaluation of Cellular Immune Responses in Subjects Chronically Infected with HIV Type 1
Sheri Dubey
AIDS Research and Human Retroviruses, 2007
View PDFchevron_right
Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells
eleni choremi
Scandinavian journal of immunology, 2011
View PDFchevron_right
Specific Immune Response to Human Immunodeficiency Virus (HIV)-1 in Patients Assessed Through the Production of Interferon-gamma and Interleukin-4 in HIV-1 p24-Activated Whole Blood Cultures: Relationship with the Viral Load in Plasma
Georges Lion , Yves Mouton
Scandinavian Journal of Immunology, 1999
View PDFchevron_right
Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study
Adriana Topan
PLOS ONE, 2021
View PDFchevron_right
An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa
Anthony Eshofonie
Clinical and Experimental Immunology, 2006
View PDFchevron_right
Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay
Paul Cameron
PloS one, 2016
View PDFchevron_right
Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
Nesrina Imami
Clinical and Experimental Immunology, 1999
View PDFchevron_right
Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy
Grazyna Galatowicz , William Lynn
Clinical Immunology, 2006
View PDFchevron_right
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
Dominique Costagliola
BMC Infectious Diseases, 2014
View PDFchevron_right
The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs
ronald moss
HIV Medicine, 2001
View PDFchevron_right
The Relationship between T Cell Proliferative Responses and Plasma Viremia during Treatment of Human Immunodeficiency Virus Type 1 Infection with Combination Antiretroviral Therapy
Gabriel Alejandro Lopz Ortiz
The Journal of Infectious Diseases, 2000
View PDFchevron_right
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination …
Gabriel Alejandro Lopz Ortiz
Journal of Infectious …, 2000
View PDFchevron_right
Short Communication: HIV Type 1 Viremia on ART Is Positively Associated with Polyclonal T Cell Proliferation in Subjects with T Cell IFN-γ Secretion Levels Comparable to Those of Uninfected Subjects
Maxwell Pistilli
AIDS Research and Human Retroviruses, 2008
View PDFchevron_right
Limiting dilution analysis of in vivo-activated (IL-2 responsive) peripheral blood lymphocytes in HIV-1-infected subjects
Vera Donnenberg
Clinical Immunology and Immunopathology, 1989
View PDFchevron_right
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
Suzanne Jurriaans
AIDS, 1999
View PDFchevron_right
Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals
Yves Mouton
2000
View PDFchevron_right
A STUDY OF IMMUNE RESPONSE AND SIDE EFFECTS OF SECOND LINE ANTIRETROVIRAL THERAPY IN HIV/ AIDS PATIENTS
IJAR Indexing
View PDFchevron_right
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group
Laurence Weiss
Lancet, 1999
View PDFchevron_right
Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA Study
Stefano Vella
The Journal of Infectious Diseases, 2004
View PDFchevron_right
Brief Communication: Consistent Subtype-Specific Anti-HIV Type 1 T Lymphocyte Responses in Indian Subjects Recently Infected with HIV Type 1
Madhuri Thakar
AIDS Research and Human Retroviruses, 2002
View PDFchevron_right
Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group
Donna Mildvan
Clinical Infectious Diseases, 2003
View PDFchevron_right
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection
Emma Fernández
AIDS, 2020
View PDFchevron_right
Immunophenotypic Markers and Antiretroviral Therapy (IMART): T Cell Activation and Maturation Help Predict Treatment Response
Donna Mildvan
The Journal of Infectious Diseases, 2004
View PDFchevron_right
Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection
A. Meyerhans
AIDS, 2000
View PDFchevron_right
Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2
STEFANIA ZANUSSI
Clinical and Experimental Immunology, 1999
View PDFchevron_right
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme- …
Vadakkuppattu Ramanathan
Clinical and Vaccine …, 2009
View PDFchevron_right
Correlation between cytokine serum levels, number of CD4+ T cells/mm³ and viral load in HIV-1 infected individuals with or without antiretroviral therapy
Carlos Rafael Laurentino de Lima
Journal of Venomous Animals and Toxins including Tropical Diseases, 2004
View PDFchevron_right
No Differences in Cellular Immune Responses between Asymptomatic HIV Type 1– and Type 2–Infected Gambian Patients
Abraham Alabi
The Journal of Infectious Diseases, 2004
View PDFchevron_right
Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeficiency
William Hildebrand
Journal of Virology, 2000
View PDFchevron_right